Online personalized intervention to prevent anxiety
Effectiveness of an Online Personalized Intervention Based on a Risk Algorithm for the Universal Prevention of Anxiety: Randomized Controlled Trial. The prevANS Study.
This study is testing an online program designed to help prevent anxiety in people by personalizing the experience based on their individual risk levels.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Malaga Academic / other |
| Locations | 1 site (Málaga) |
| Trial ID | NCT05682365 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to design, develop, and evaluate an online personalized intervention for the universal prevention of anxiety disorders in the general population. It will utilize a randomized controlled trial design with two parallel arms and a 12-month follow-up period. Participants will be recruited through a web platform and will be randomly assigned to either the prevANS intervention, which is self-guided and accessible via a website or smartphone app, or a control group. The intervention's intensity will vary based on the individual's risk level for developing anxiety disorders.
Who should consider this trial
Good fit: Ideal candidates for this study are Spanish and Portuguese adults without anxiety disorders at baseline, as indicated by a GAD-7 score of less than 10.
Not a fit: Patients with serious mental illnesses, cognitive impairments, or those currently undergoing psychological treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the incidence of anxiety disorders in the general population.
How similar studies have performed: Other studies have shown promise in using online interventions for mental health, suggesting that this approach could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * GAD-7 \<10 at baseline * GAD-7 ≥10 at baseline and a negative diagnosis of anxiety disorders by CIDI Exclusion Criteria: * Not have a smartphone and internet for personal use * Unable to speak Spanish * Documented terminal illness * Documented cognitive impairment * Documented serious mental illness (psychosis, bipolar, addictions, etc.) * Being involved in any psychological intervention or treatment
Where this trial is running
Málaga
- Facultad de Psicología y Logopedia — Málaga, Spain (Recruiting)
Study contacts
- Principal investigator: Patricia Moreno-Peral, PhD — University of Malaga
- Study coordinator: Patricia Moreno-Peral, PhD
- Email: predictmalaga@hotmail.com
- Phone: +34951030534
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.